BioNote, Inc. (KRX:377740)

BioNote Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	592,963	480,684	433,228	874,096	-	-
Market Cap Growth	19.92%	10.95%	-50.44%	-	-	-
Enterprise Value	246,487	83,431	16,432	174,842	-	-
Last Close Price	5850.00	4518.73	3891.81	7866.13	-	-
PE Ratio	5.04	8.70	-	2.84	-	-
PS Ratio	5.15	4.68	4.81	1.82	-	-
PB Ratio	0.35	0.29	0.28	0.55	-	-
P/TBV Ratio	0.35	0.30	0.28	0.55	-	-
P/FCF Ratio	28.70	10.13	-	4.23	-	-
P/OCF Ratio	18.76	8.30	-	3.51	-	-
EV/Sales Ratio	2.14	0.81	0.18	0.37	-	-
EV/EBITDA Ratio	1.84	4.09	-	0.58	-	-
EV/EBIT Ratio	1.96	6.83	-	0.59	-	-
EV/FCF Ratio	11.93	1.76	-	0.85	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.13	0.19	-	0.00	0.00	0.00
Debt / FCF Ratio	0.17	0.08	-	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.20	-0.24	-0.25	-0.45	-0.38	-0.32
Net Debt / EBITDA Ratio	-12.72	-19.68	10.14	-2.39	-1.03	-0.36
Net Debt / FCF Ratio	-16.77	-8.46	48.46	-3.48	-1.00	-0.95
Asset Turnover	0.07	0.06	0.05	0.30	0.53	1.28
Inventory Turnover	1.96	1.86	1.86	1.94	1.87	1.71
Quick Ratio	33.06	18.20	39.35	14.94	4.84	2.80
Current Ratio	35.92	19.69	42.26	16.66	5.42	3.12
Return on Equity (ROE)	7.15%	3.46%	-1.30%	21.43%	70.80%	141.00%
Return on Assets (ROA)	0.68%	0.46%	-1.76%	11.38%	25.01%	70.87%
Return on Invested Capital (ROIC)	1.21%	0.77%	-4.62%	26.34%	59.77%	154.08%
Return on Capital Employed (ROCE)	1.10%	0.70%	-3.00%	17.30%	34.20%	83.30%
Earnings Yield	19.84%	11.50%	-4.73%	35.21%	-	-
FCF Yield	3.48%	9.87%	-1.88%	23.66%	-	-
Dividend Yield	3.42%	4.43%	-	-	-	-
Payout Ratio	17.23%	36.94%	-	16.23%	7.38%	-
Buyback Yield / Dilution	0.77%	0.08%	-8.16%	-0.64%	-0.14%	-11.08%
Total Shareholder Return	4.20%	4.51%	-8.16%	-0.64%	-0.14%	-11.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.